Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative DR

This post hoc analysis of the CLARITY randomized clinical trial investigates the distribution of neovascularization in patients with proliferative diabetic retinopathy and the topographical response of neovascularization to treatment with aflibercept or panretinal photocoagulation.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research